Byetta Cancer Lawyer: Recent Studies Have Shown That Byetta May Cause An Increased Risk of Both Thyroid Cancer and Pancreatic Cancer by Byetta Cancer Lawyer

Byetta Cancer Lawyer: Recent Studies Have Shown That Byetta May Cause An Increased Risk of Both Thyroid Cancer and Pancreatic Cancer by Byetta Cancer Lawyer Jason S. Coomer

Persons taking the injectable diabetes drug, Byetta (Exenatide), should be aware that this diabetes drug may cause an increased health risk of both thyroid cancer as well as pancreatic cancer.  It is important for any person taking Byetta to communicate with their physician to determine the best course of treatment for their diabetes and to make sure that they are aware of any potential cancer symptoms if they continue to take the drug.

If you are taking Byetta and have been diagnosed with thyroid cancer or pancreatic cancer, please feel free to contact Byetta Thyroid Cancer Lawyer and Byetta Pancreatic Cancer Lawyer, Jason S. Coomer about a potential lawsuit. 

Byetta Pancreatic Cancer Lawsuits and Byetta Thyroid Cancer Lawsuits

Byetta Pancreatic Cancer Lawsuits and Byetta Thyroid Cancer Lawsuits are in the process of being reviewed and filed as recent scientific evidence indicates that the injectable diabetes drug, Byetta (Exenatide), may cause an increased risk of thyroid cancer and pancreatic cancer.  Pancreatic Cancer is an extremely deadly form of cancer.  Most people diagnosed with Pancreatic Cancer or Cancer of the Pancreas do not survive beyond the five years and many are given much less time as Pancreatic Cancer is hard to detect.  Early detection for both pancreatic cancer and thyroid cancer is a key to surviving cancer and preventing it from spreading.

Prior 2009, the FDA received more than 30 adverse reports from Byetta users. Base on this information, the FDA directed Amylin to conduct six post-marketing studies regarding potential health risks associated with the use of Byetta including the risk of thyroid cancer and pancreatic cancer. Additionally, the FDA has expressed concern that all extended-release diabetes drugs belonging to Byetta's family of GLP-1 receptor agonists may be linked to thyroid tumors based on tests conducted on rats and monkeys.

For the over 1 million users of Byetta, it is important to be aware of these cancer health risks and contact your doctor if you are experiencing any potential cancer symptoms.